Humana Inc.

HUM · NYSE · Stock · Healthcare
$426.91
+1.55% today
Delayed price,

What Humana does

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Key facts

Sector
Healthcare
Industry
Healthcare Plans
Market cap
$51.26B
P/E (ttm)
40.4
Forward P/E
25.0
Dividend yield
0.84%
Beta
0.74
Profit margin
0.9%
Employees
67,060
Headquarters
Louisville, KY, United States
Exchange
NYSE

Performance

1 Month
+10.5%
3 Months
+6.7%
6 Months
+108.1%
1 Year
+55.2%
5 Years
+1.7%
$163.1152-week range$456.50
Biggest setback — last 12 months
-43.1%
20 Oct 2025 → 9 Mar 2026
Fell from $290.65 to $165.43 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+161.1%
9 Mar 2026 → 5 Oct 2026
Ran from $165.43 to $431.87 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$375.72 (-12.0%)$426.91$485.07 (+13.6%)
3 Months$342.18 (-19.8%)$426.91$532.62 (+24.8%)
6 Months$312.22 (-26.9%)$426.91$583.73 (+36.7%)
12 Months$274.27 (-35.8%)$426.91$664.50 (+55.7%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 44.3%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 238 shares at $384.91 — HILZINGER KURT J, Director · 2026-10-02
Acquired 2,549 shares — Nundy Shantanu, Chief Medical Officer · 2026-09-03
Acquired 544 shares — Smith Paul John, Director · 2026-08-04
Acquired 544 shares — Crawford Frederick John, Director · 2026-08-04
Acquired 233 shares at $392.32 — HILZINGER KURT J, Director · 2026-07-02
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.